Volatility ruled the roost in mid-afternoon trade as the Sensex once again sink in negative zone after briefly turning positive. The Nifty also extended losses soon after reaching near the flat line. At 14:30 IST, the barometer index, the S&P BSE Sensex, was down 45.12 points or 0.13% at 35,131.30. The Nifty 50 index was down 18.95 points or 0.18% at 10,699.10. The broader market depicted weakness. Most FMCG stocks declined. Negative global stocks weighed on the domestic bourses.
Local stocks were trading with small losses in early trade on negative Asian stocks. Key benchmark indices extended fall in morning trade. Sustained selling pressure in index pivotals kept the key benchmark indices subdued in mid-morning trade. Market pared losses in afternoon trade.
The S&P BSE Mid-Cap index was down 1.08%. The S&P BSE Small-Cap index was down 0.79%. Both these indices underperformed the Sensex.
The broad market depicted weakness. There were more than two losers against every gainer on BSE. 1,851 shares fell and 710 shares rose. A total of 133 shares were unchanged.
Oil and Natural Gas Corporation (ONGC) rose 1.45% after the company said that it has drilled 503 wells in 2017-18, which is the highest number of wells drilled in last 27 years. The announcement was made after market hours yesterday, 2 May 2018.
Among the 503 wells, 119 exploratory and 384 development wells were drilled. In order to assess the prospectivity of existing acreages in a time-bound manner and add to the company's reserve base, more focus was laid on exploratory drilling.
During FY 2018, ONGC's planned capex outlay on drilling activities was Rs 16038 crore with a target to drill 496 wells including 110 exploratory and 386 development wells. However, the company has drilled 503 wells at a cost of approx Rs 14200 crore which is 11.5% lower than the budget outlay. The initiatives taken by the company to optimize cost and enhance operational efficiencies has yielded additional savings in the fiscal year ended March 31 March 2018.
Also Read
This year, ONGC has set a capex outlay of Rs 17615 crore on drilling activities. There is a significant upside in the number of deepwater development wells planned by the company. The company has set an ambitious target to drill 535 wells, of which 24 are deep-water development wells as part of Cluster-2 development of KG-DWN-98/2 project, off the EastCoast of India. The company is also set to drill 30 wells as part of its CBM development project.
Infosys shed 0.16%. Infosys after market hours yesterday, 2 May 2018 announced a partnership with Astound, an enterprise software company applying machine learning and natural language processing to automate services and support for enterprises. Through this partnership, Astound's Artificial Intelligence (AI) platform will be embedded into Infosys Enterprise Service Management Cafto deliver AI-driven automation to large enterprises and their employees.
The solution reduces call volume, mean time to resolve tickets, improves customer satisfaction and reduces support costs by providing recommendations to users in real time.
Most FMCG stocks declined. Britannia Industries (down 1.19%), Colgate-Palmolive (India) (down 2.2%), Dabur India (down 0.54%), Hindustan Unilever (down 1.21%), Marico (down 1.55%), Nestle India (down 0.55%), Tata Global Beverages (down 1.18%) and Bajaj Corp (down 0.71%) fell.
Procter & Gamble Hygiene and Health Care (up 0.65%), Jyothy Laboratories (up 0.55%), GlaxoSmithkline Consumer Healthcare (up 0.36%) and Godrej Consumer Products (up 0.71%) rose.
Biocon lost 5.58% after the company's sterile drug product manufacturing facility in Bengaluru received observations from US and European regulators. The announcement was made after market hours yesterday, 2 May 2018.
The US Food and Drug Administration (USFDA) completed a pre-approval inspection of the company's sterile drug product manufacturing facility in Bangalore this week and issued a Form 483 with 7 observations. The observations are largely procedural and aimed at continuous improvement. The company will respond to the FDA with a corrective and preventive action plan in a timely manner.
Further, Biocon has also received the preliminary report from the European Regulator post inspection of the company's sterile drug product facility in Bangalore in March 2018. The report lists 6 major observations with no observation classified as critical. Biocon will submit a corrective and preventive action plan to the European inspection agency within the stipulated time period.
Overseas, European equities were trading lower as investors closely monitored trade talks between the US and China and digested new earnings reports.
Asian stocks fell after the Federal Reserve reiterated plans to continue raising rates gradually amid firming inflation. Japan markets are closed for a four-day holiday weekend. US stocks fell yesterday, 2 May 2018 as investors assessed the US Federal Reserve's signal that it's in no rush to raise rates even as inflation rises to its target.
The Federal Reserve on Wednesday kept a key US interest rate steady, saying that while inflation has moved higher, it's likely to run near the central bank's 2% target in the coming months. The central bank maintained its fed funds at a range of 1.5%-1.75%.
In its statement, the Fed noted the latest readings that show both overall and core inflation have moved close to the central bank's 2% goal. Fed officials were split between whether to raise rates three or four times this year.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content